Literature DB >> 22321369

Increased expression of valosin-containing protein in the skin of patients with amyotrophic lateral sclerosis.

Hiroaki Ishikawa1, Kanako Yasui, Yoshihiko Oketa, Megumi Suzuki, Seiitsu Ono.   

Abstract

Valosin-containing protein (VCP) may have a pivotal role in ubiquitin-dependent protein degradation and is implicated in the pathogenesis of neurodegenerative diseases. Skin studies from patients with amyotrophic lateral sclerosis (ALS) have shown unique abnormalities. We undertook a quantitative immunohistochemical study of VCP in the skin from patients with ALS and control participants. The proportion of VCP-positive (VCP+) cells in the epidermis in patients with ALS was significantly higher (p<0.001) than in controls. There was a significant positive relationship (r=0.59, p<0.01) between this proportion and duration of illness in patients with ALS. The optical density of VCP+ cells in the epidermis in patients with ALS was higher (p<0.001) than in controls. There was a significant positive relationship (r=0.61, p<0.01) between the immunoreactivity and duration of illness in patients with ALS. These data suggest that changes in VCP identified in skin from patients with ALS are likely to be related to the disease process. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22321369     DOI: 10.1016/j.jocn.2011.05.044

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  7 in total

Review 1.  Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

Authors:  Emanuele D'Amico; Pam Factor-Litvak; Regina M Santella; Hiroshi Mitsumoto
Journal:  Free Radic Biol Med       Date:  2013-06-21       Impact factor: 7.376

2.  Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients.

Authors:  Elisa Perciballi; Federica Bovio; Jessica Rosati; Federica Arrigoni; Angela D'Anzi; Serena Lattante; Maurizio Gelati; Fabiola De Marchi; Ivan Lombardi; Giorgia Ruotolo; Matilde Forcella; Letizia Mazzini; Sandra D'Alfonso; Lucia Corrado; Mario Sabatelli; Amelia Conte; Luca De Gioia; Sabata Martino; Angelo Luigi Vescovi; Paola Fusi; Daniela Ferrari
Journal:  Antioxidants (Basel)       Date:  2022-04-22

3.  Bioenergetic markers in skin fibroblasts of sporadic amyotrophic lateral sclerosis and progressive lateral sclerosis patients.

Authors:  Kathryne Kirk; Chris Gennings; Jonathan C Hupf; Saba Tadesse; Marilena D'Aurelio; Hibiki Kawamata; Federica Valsecchi; Hiroshi Mitsumoto; Giovanni Manfredi
Journal:  Ann Neurol       Date:  2014-08-21       Impact factor: 10.422

4.  Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.

Authors:  Csaba Konrad; Hibiki Kawamata; Kirsten G Bredvik; Andrea J Arreguin; Steven A Cajamarca; Jonathan C Hupf; John M Ravits; Timothy M Miller; Nicholas J Maragakis; Chadwick M Hales; Jonathan D Glass; Steven Gross; Hiroshi Mitsumoto; Giovanni Manfredi
Journal:  Mol Neurodegener       Date:  2017-10-24       Impact factor: 14.195

5.  Quantitative proteomics analysis of young and elderly skin with DIA mass spectrometry reveals new skin aging-related proteins.

Authors:  Jing Ma; Mengting Liu; Yaochi Wang; Cong Xin; Hui Zhang; Shirui Chen; Xiaodong Zheng; Xuejun Zhang; Fengli Xiao; Sen Yang
Journal:  Aging (Albany NY)       Date:  2020-06-29       Impact factor: 5.682

Review 6.  Genetics of amyotrophic lateral sclerosis: an update.

Authors:  Sheng Chen; Pavani Sayana; Xiaojie Zhang; Weidong Le
Journal:  Mol Neurodegener       Date:  2013-08-13       Impact factor: 14.195

7.  Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutant.

Authors:  Takashi Ayaki; Hidefumi Ito; Hiroko Fukushima; Takeshi Inoue; Takayuki Kondo; Akito Ikemoto; Takeshi Asano; Akemi Shodai; Takuji Fujita; Satoshi Fukui; Hiroyuki Morino; Satoshi Nakano; Hirofumi Kusaka; Hirofumi Yamashita; Masafumi Ihara; Riki Matsumoto; Jun Kawamata; Makoto Urushitani; Hideshi Kawakami; Ryosuke Takahashi
Journal:  Acta Neuropathol Commun       Date:  2014-12-10       Impact factor: 7.801

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.